RESULTS Act Reforming and Enhancing Sustainable Updates to Laboratory...
To amend title XVIII of the Social Security Act to provide long-term stability for Medicare beneficiary access to clinical diagnostic laboratory tests by improving the accuracy of, and feasibility of data collection for, the private payor-based fee schedule payment rates applied under the Medicare program for such tests, and for other purposes.
This bill, HB5269, aims to improve the way Medicare pays for clinical diagnostic laboratory tests. It wants to make sure these payments are accurate and based on reliable data, ensuring that Medicare beneficiaries can continue to access these important tests without issues. The bill was introduced on September 10, 2025, and has been referred to the Committee on Energy and Commerce and the Committee on Ways and Means for further review.
The bill would primarily affect Medicare beneficiaries who rely on laboratory tests for their healthcare, as well as the providers who perform these tests. By ensuring that payment rates are accurate and data collection is reliable, the bill aims to stabilize access to these essential services. Additionally, it would impact the entities responsible for setting and managing these payment rates.
As of the latest update on September 10, 2025, the bill has been introduced in the House and referred to the relevant committees for further consideration. There have been no further actions or hearings scheduled yet, but the committees will review the bill and may hold hearings to gather more information and input from stakeholders.
